An underground economy for unlicensed slimming medications is propelled by TikTok fitness influencers and sellers on communication apps, based on recent findings.
Investigational Drug Gaining Traction Via Social Media
Retatrutide, which is still in research studies, is being advertised by social media influencers for its supposed fat-burning effects. Followers are encouraged to message these accounts directly for supplier links, while also receiving promotional offers.
Active Trade on Social Networks
Separately, a robust trade exists on Telegram, where groups with numerous of participants share comparison images, injection guides and claims of rapid UK delivery. Sellers market the substance there before directing buyers to other platforms for transactions.
Learning About Retatrutide
This medication is an investigational injectable developed by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and glucagon. Preliminary studies indicate it could help individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being promoted digitally as the successor to Ozempic.
Healthcare Professionals Voice Worries
Nevertheless, doctors and chemists have warned that the distribution of what is still an unlicensed medication in the UK is worrisome and could lead to individuals administering substances of uncertain source.
Several professionals stated the demand for the experimental drug could be linked to the rising price of approved slimming treatments such as Mounjaro.
Regulatory Status and Enforcement
Selling retatrutide on TikTok or Telegram is prohibited in the United Kingdom, as it is an unapproved drug that must not be promoted or distributed for personal consumption under the Human Medicines Regulations 2012.
Some content creators attempt to sidestep the rules by referring to the drug as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled drug, but advertising and distribution can still breach pharmaceutical, marketing, and customer laws, risking fines, legal action or imprisonment.
Service Reaction and Material Removal
According to the social media company, the platform has removed violative material and prohibited related hashtags and query recommendations. The organization stated it was dedicated to maintaining the platform secure and investing in strengthening enforcement strategies.
Digital Marketplace Activities
Research also discovered communities with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which operates like a public directory. Entering “retatrutide” immediately displays channels with thousands of users, filled with images of slimming results, positive testimonials and step-by-step instructions for mixing or injecting at home.
Within minutes of entering one group, a vendor posted contact information, where most transactions take place. The seller provided an guidebook and guaranteed delivery within 48 hours. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. None asked about body mass, medical conditions or previous experience.
Product Information and Pricing
Inside these groups, posts display dark colored packages with postal service labels, claiming to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”
Buyers can choose between powder vials, prepared at home with sterile water, or pre-filled injectors typically priced at £160 for 20mg. When questioned how long a pen should last, sellers give conflicting answers ranging from a few weeks to “depends on your body”.
Service Moderation and Security Actions
A representative for Telegram stated it regularly monitored dangerous content on its service including content that promoted the “misuse of controlled medications”. The organization added that it eliminated “millions of pieces of harmful content each day”.
Medical Professional Warnings
“Individuals are administering substances they can’t verify. Although the research behind retatrutide is sound, these online versions may not include what they advertise,” said Jason Murphy, the director of pharmaceutical services at a pharmacy service.
A medical professional of an online medical service connected the increase in demand to current price rises for approved slimming medications such as Mounjaro. “With costs increasing, patients are turning to social media. But counterfeit treatments are extremely risky. You can’t be certain what’s inside or whether the conditions they were made in was sterile,” she said.
Her staff has previously encountered individuals harmed by personal administration from unverified suppliers. “We recognize the disappointment, but buying from Telegram or WhatsApp is taking chances with your well-being,” stated Wyllie. “These materials could be contaminated or incorrectly dosed.”
Producer Statement
A representative from Eli Lilly said the substance was in phase 3 clinical trials and had not been evaluated or authorized by any regulatory agency anywhere in the world. “Consequently at this point no one can market [it] for personal consumption,” they said, noting that any product “falsely representing itself as a company investigational product not yet approved … may subject users to possibly serious health risks”.
